From left: Dr. James Lomas (University of York), Maximilian Salcher-Konrad (LSE and Austrian Public Health Institute), Dr. Christine Leopold (Utrecht University), Dr. Anita Wagner (Harvard Medical School), Dr. Huseyin Naci (LSE), Dr. Courtney Davis (King’s College London), Steven Woloshin (Dartmouth Institute of Health Policy and Clinical Practice).
Dr Huseyin Naci, one of Health Policy's faculty members recently coordinated a three-day event bringing to London collaborators from Harvard Medical School, the Dartmouth Institute for Health Policy and Clinical Practice, King’s College London, and Utrecht University.
Meeting in person and spending time together was essential to establish a research roadmap to advance their collaboration on pharmaceutical policy. To conduct interdisciplinary research that evaluates, informs and shapes pharmaceutical policies to maximise the benefits and minimise the harms of new drugs for patients, health systems, and societies globally, the group is also developing a unique initiative the Pharmaceutical Policy Lab and working on a number of funding proposals.
If you are working on an international project and want to discuss how we can support you, contact our team and watch this space for the next call for applicants in 2026.